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If medical aids are forced to 
pay the full fee charged by 
doctors, as the Council for 
Medical Schemes (CMS) 
insists they do, then either 
medical aid subscriptions will become 
unaffordable or schemes will collapse, 
denying people their constitutional rights.
This is the view of Dr Humphrey Zokufa 
of the Board of Healthcare Funders (BHF), 
which represents over 70% of existing medical 
aid schemes. He signalled to Izindaba the 
BHF’s intention to forge ahead in securing 
either a High Court or Constitutional Court 
interpretation of the contentious Regulation 8 
of the Medical Schemes Act.
Zokufa said his board would be engaging 
with Dr Aaron Motsoaledi, National Minister 
of Health, while lobbying all medical schemes 
to support their court bid. Discovery Health, 
the largest medical aid administrator, pulled 
out the BHF several years ago. It disagrees 
with the BHF’s court approach. The BHF 
wants Regulation 8 either declared ‘ultra vires 
(without legal force) or unconstitutional, 
arguing that it fails to promote affordability 
and accessibility to healthcare (Section 27 
of the Constitution)’. Regulation 8 itself says 
simply, medical aid schemes must ‘pay in 
full’ the claims of patients, but is silent as to 
whether this means the maximum rate as 
defined by each medical scheme’s rules, or 
the actual full service provider fee. The CMS 
vigorously asserts the latter while medical 
aids claim the former (which can amount 
to as little as a quarter of the actual bill – 
although the pay-out ceilings are clearly 
stated in the rules that members sign up for). 
Zokufa accuses Dr Monwabisis Gantsho, 
the new CMS chief, of being ‘disingenuous’ 
and currying favour with contributors 
by threatening medical schemes who 
have ignored CMS letters demanding an 
explanation as to why they are ignoring 
Regulation 8. (In November 2008, the CMS’s 
Appeal Board ruled that service providers 
must ‘pay in full’ all invoices related to the 
costs of providing healthcare services for 
Prescribed Minimum Benefits (PMBs) – 
without taking the rules of the respective 
medical scheme into consideration). Zokufa 
says Gantsho knows that a BHF court action 
is looming. He sees the CMS broadside as 
coming close to intimidation of all medical 
aids, ‘the implication being that if you support 
the BHF in a court case it would amount to 
frivolous expenditure’. He says the regulator 
(CMS) is being ‘reckless’ by demanding 
the non-productive use of medical aid 
contributors’ money; ‘He [Gantsho] must 
appreciate the negative impact it would have 
on individual members if their contributions 
were to increase to make up for those [full] 
payouts. The schemes are only as strong 
as their membership base’. Zokufa revealed 
that the BHF was assiduously gathering 
data on abuse of the system by anaesthetists, 
pathologists and surgeons (via several 
procedures, including caesarean sections) 
to see what patterns emerged. Gantsho had 
challenged the BHF to ‘produce evidence’ of 
such abuse.
CMS view of Regulation 8 
‘irrational’ – Zokufa
Zokufa added, ‘Basically the way it [the 
system] works now is totally irrational – 
you cannot with legislation oblige certain 
activities [i.e. pay at the provider-charged 
rates] while opening up a faucet on the other 
side with no obligations or controls’. The 
BHF has twice asked for exemption from 
the Competitions Commission Act, which it 
says ‘unfairly’ resulted in a 2004 ruling that 
medical schemes may not collectively bargain 
with healthcare providers (the commission 
holding that this was anti-competitive 
and could lead to price-setting). Zokufa 
said the impending comprehensive private 
healthcare probe[1] came after Motsoaledi 
gave the BHF a lengthy audience on the 
matter, later approaching the commission 
and speaking to Dr Ebrahim Patel, his 
Economic Development cabinet colleague. 
‘We expect the Commission to do a good 
job and drill down wherever they can, using 
their power of subpoena to get to the bottom 
of anomalies like the sudden CMS annual 
report surpluses of the last two financial 
years against a backdrop of deficits for the 
previous 5 - 10 years.’
The medical aid definition of Regulation 8 
will remain the painful everyday reality for 
medical aid contributors, whether they have 
expensive comprehensive cover, a simple 
hospital plan or whether their potentially 
catastrophic condition qualifies them for 
PMB medication. The underlying cause of 
the standoff (besides the unclear regulation) 
is the absence of any official tariff guidelines, 
enabling healthcare professionals to charge 
up to four times the medical aid ceilings. The 
Health Professions Council of South Africa 
(HPCSA) whose mission statement is ‘to 
guide the professions and protect the public’ 
had a short-lived shot at proposing ‘fair’ 
tariff guidelines last year – eliciting howls 
of outrage from the medical profession 
which said they were so low as to be out 
of touch with reality. The HPCSA is now 
consulting more widely in an ambitious bid 
to get multiple role players to agree on what 
constitutes ‘fair’ tariff guidelines for private 
healthcare. 
Motsoaledi ‘tired’ of 
legal wrangling
Meanwhile a thoroughly disgruntled and 
impatient Motsoaledi has vowed to enact 
legislation to correct the ‘untenable’ situation, 
but it could take years. It will probably serve 
him to await the findings of the subpoena-
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strengthened Competitions Commission 
enquiry into the private healthcare industry 
– which only begins in January next year. 
Meanwhile, it is to the courts we will look, 
courtesy of the BHF. Whichever court it is, 
the judges may even decide that it is beyond 
their ambit to tamper with Parliament’s law-
making powers (i.e. to tinker with faulty 
legislation). Zokufa says his medical scheme 
members literally cannot afford to wait for 
the politicians to amend the law, as ageing 
populations, more chronic diseases and 
cancer, costly new treatments and drugs 
inexorably push healthcare costs higher than 
the consumer price index. Lined up on the 
side of the CMS (though some may enter the 
fray as ‘friends of the court’) are the South 
African Medical Association (with 17  000 
clinician members), the National Minister 
of Health, the Pharmaceutical Society 
of South Africa, Mediclinic SA Ltd, the 
Multiple Sclerosis Society of South Africa 
and National Renal Care. 
Motsoaledi, button-holed by Izindaba at the 
annual Medical Research Council’s awards 
ceremony on 30 October, professed to still 
being intent on getting the Competitions 
Commission to overrule its decade-old 
ruling that tariff setting was collusive – and 
getting stakeholders back to the negotiating 
table. ‘I don’t believe the tariff setting was 
collusive. They must just do away with that 
ruling, it’s the quickest and fastest way. Now, 
whoever puts up suggested guidelines … 
you just know there’s going to be a court 
case. There’s been court case after court 
case [since the High Court invalidated the 
National Health Reference Price List in 
2010]. All I kept telling the Competitions 
Commission is that they made the wrong 
ruling. It’s causing havoc in the [private] 
healthcare sector,’[2] he said. He said treating 
healthcare as a market commodity (instead 
of a ‘public good’) was hugely inappropriate. 
‘How do you go back when you can’t talk 
to the stakeholders and say there’s a [High 
Court] ruling here?! That’s why I’ve been 
chasing the Competitions Commission. In 
their own wisdom they decided to do the 
market enquiry, which I welcome, but I must 
tell you it’s not what I asked for.’ He said 
negotiation, while not a perfect mechanism, 
was far better than the current impasse, and 
reiterated his call for a pricing commission to 
provide the government with tariff guidance. 
Pushed as to when he would be approaching 
Thembenkosi Bonakele, the then new Acting 
Competitions Commissioner, he said he had 
‘only just met him two days ago,’ but would 
shortly be ‘engaging with him’. ‘I’m not in 
charge of them. Things are very complex 
and technical but I still believe they can 
do it [revoke their 10-year-old ruling]. If 
that happens we can go back to Parliament 
and show them [his fellow members of 
Parliament] that they [the legislators] are 
making life difficult [via the existing Act and 
Regulation 8].’ 
Motsoaledi said the CMS ruling gave a 
perverse incentive to doctors. ‘Give me 
any area of industry where you can just 
put something on the invoice and say you 
must pay this?’ he asked. He agreed with 
Zokufa that medical schemes were too 
heavily regulated, ‘while there’s nothing on 
the provider side’. He also revealed that the 
white paper would almost certainly push 
general practitioners (GPs) back into the 
role of gatekeeper. ‘Many specialists will get 
angry with me, but I don’t understand why 
we’ve arrived at a situation where patients 
can just wake up and go to any specialist 
as a first port of call. In law you don’t go to 
an advocate first, you consult an attorney. If 
this happened in the legal system it would be 
hugely expensive. We need to be delegating 
everything downwards instead of upwards,’ 
he said, citing the success of the Nurse 
Initiated Management of Antiretroviral 
Therapy (NIMART). ‘I mean, there was no 
chance of us reaching 2.1 million people if 
we didn’t go to NIMART.’ He could not see a 
National Health Insurance working without 
using GPs as gatekeepers and without nurses 
becoming more utilitarian. 
Zokufa said his central argument was 
not about quantum, but survival. If medical 
schemes went out of business, one by one, 
millions of current members would suffer 
an infinitely worse fate than just coughing 
up ever-increasing annual premiums. 
Two years ago, the BHF made an abortive 
attempt in the Pretoria High Court to 
obtain a solid ruling on the meaning of ‘pay 
in full,’ but it was thwarted by a technical 
ruling that it did not represent the majority 
of medical aid schemes. Almost exactly a 
year later, a BHF petition to the Supreme 
Court of Appeal in Bloemfontein was 
dismissed and the technical Pretoria ruling 
upheld.[3] Meanwhile, the major role players 
delivering and regulating private medical 
schemes continue with the fevered debate 
– aimed at winning the ‘hearts and minds’ 
of their 9 million-strong constituency 
(17% of the population), and using broad 
human rights brush strokes – before our 
all-encompassing universal health coverage 
kicks in. The Competition Commission’s 
time-consuming task will probably leave 
those of us still able to afford medical aid 
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Motsoaledi said the CMS ruling 
gave a perverse incentive to 
doctors. ‘Give me any area of 
industry where you can just put 
something on the invoice and 
say you must pay this?’ he asked. 
He agreed with Zokufa that 
medical schemes were too heavily 
regulated, ‘while there’s nothing 
on the provider side’.
Zokufa said his central 
argument was not about 
quantum, but survival. If 
medical schemes went out of 
business, one by one, millions 
of current members would 
suffer an infinitely worse fate 
than just coughing up ever-
increasing annual premiums.
